Cerbios-Pharma SA

With over 40 years in the pharmaceutical industry, Cerbios is a privately held company with headquarter in Barbengo-Lugano, Switzerland, specialising in the development and manufacture of both chemical and biological APIs for its partners worldwide. Beyond the development of its own product pipeline, Cerbios offers exclusive third-party CDMO services for High Potency Active Pharmaceutical Ingredients (HPAPIs), recombinant proteins and Antibody Drug Conjugates (ADCs) from preclinical through clinical to commercial supply.

News from this company

Strategy & Management

Innovative Chemistry Between Mountains and Lakes

09.12.2019 -

Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan...

Strategy & Management

Experts Statements: Gabriel Haering, Cerbios Pharma

05.09.2019 -

The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021.

News

Francesca Scarpitta Joins Cerbios as Director of HPAI Manufacturing Units

24.01.2019 -

Cerbios has appointed Francesca Scarpitta as director of the company’s high potency active ingredients (HPAIs) production units.

News

Cerbios Expands HPAI Manufacturing Capacity

24.01.2019 -

Lugano, Switzerland-based chemical and biological API manufacturer Cerbios announced that its board of directors has approved the installation of a new production line in...

Strategy & Management

Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development

21.09.2016 - On February 15th, 2016, Cerbios Pharma officially opened its new R&D Centre in Lugano, Switzerland. During the past 15 years, Cerbios has heavily invested in infrastructures, in...

Plant Construction & Process Technology

Value Over Price

11.09.2013 - Quality First - As the trend of specialized medicine continues to grow, so does the development of highly potent active pharmaceutical ingredients, better known as HPAPIs. Handling...

Contact